Introduction: Effective blinding is especially challenging in randomized controlled trials
(RCTs) involving psychedelics due to the inherent alterations in consciousness that these …

Abstract Purpose of Review In this narrative review, we discuss evidence for psilocybin-and
LSD-assisted treatment of alcohol use disorder (AUD) and major depressive disorder …

The mechanisms by which Psilocybin Therapy (PT) improves depression remain an
important object of study, with scientists actively exploring acute psychological experiences …

Abstract Floatation-REST (Reduced Environmental Stimulation Therapy) minimizes
stimulation of the nervous system by immersing subjects in an environment without sound or …

In this paper, the case study of ketamine as a new treatment for severe depression is used to
outline the challenges of repurposing established medicines and we suggest potential …

In den letzten Jahren erlebte die klinische Forschung zur therapeutischen Wirksamkeit von
Psychedelika eine Art Renaissance. Der aktuelle Stand wissenschaftlicher Erkenntnisse zur …

As clinical trials for psychedelics move into phase III in the USA, Europe must address its lag
in integrating professional education around psychedelic-assisted therapy (PAT) and …

Objective To capture UK medical students' self-reported knowledge and harm assessment of
psychedelics and to explore the factors associated with support for changing the legal status …

Depression is a serious psychiatric disorder with a high incidence of morbidity and mortality
and psilocybin with psychotherapy has emerged as a promising potential in the treatment of …

Gegenstand und Ziel Der vorliegende Artikel beschäftigt sich mit der Behandlung von
psychischen Erkrankungen mit psychedelischen Substanzen aus einem …